• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Pulmonary Drug Delivery Systems Market

Global Pulmonary Drug Delivery Systems Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • Published Date : 12 Jun 2018
  • Global Info Research
  • Category : Medical Devices
  • Pages : 152

Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.

Scope of the Report:
This report focuses on the Pulmonary Drug Delivery Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
With better performance, the development of DPIs is faster than the MDIs. In the future, DPIs will occupy larger market share and replace the MDIs gradually. In addition, the market share of nebulizers will be smaller.
As WHO said, the COPD will become the world's third-leading cause of death by 2030. With the air pollution more and more serious, patients with respiratory diseases will be more and more, which means larger and larger demand for pulmonary drug delivery systems.
The worldwide market for Pulmonary Drug Delivery Systems is expected to grow at a CAGR of roughly 5.3% over the next five years, will reach 3490 million US$ in 2023, from 2560 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
    3M
    GSK
    AstraZeneca
    Cipla
    Chiesi
    Boehringer Ingelheim
    Aptar
    Novartis
    Philips Respironics
    Omron Healthcare
    PARI
    Skyepharma
    CareFusion
    Shanghai Huarui
    Taian Character
    Chia Tai Tianqing

Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Nebulizers
    Dry Powder Inhaler (DPI)
    Metered Dose Inhaler (MDI)

Market Segment by Applications, can be divided into
    COPD
    Asthma
    Others

There are 15 Chapters to deeply display the global Pulmonary Drug Delivery Systems market.
Chapter 1, to describe Pulmonary Drug Delivery Systems Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pulmonary Drug Delivery Systems, with sales, revenue, and price of Pulmonary Drug Delivery Systems, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pulmonary Drug Delivery Systems, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pulmonary Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pulmonary Drug Delivery Systems sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source	
Table of Contents

1 Market Overview
    1.1 Pulmonary Drug Delivery Systems Introduction
    1.2 Market Analysis by Type
        1.2.1 Nebulizers
        1.2.2 Dry Powder Inhaler (DPI)
        1.2.3 Metered Dose Inhaler (MDI)
    1.3 Market Analysis by Applications
        1.3.1 COPD
        1.3.2 Asthma
        1.3.3 Others
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2013-2023)
            1.4.1.2 Canada Market States and Outlook (2013-2023)
            1.4.1.3 Mexico Market States and Outlook (2013-2023)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2013-2023)
            1.4.2.2 France Market States and Outlook (2013-2023)
            1.4.2.3 UK Market States and Outlook (2013-2023)
            1.4.2.4 Russia Market States and Outlook (2013-2023)
            1.4.2.5 Italy Market States and Outlook (2013-2023)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2013-2023)
            1.4.3.2 Japan Market States and Outlook (2013-2023)
            1.4.3.3 Korea Market States and Outlook (2013-2023)
            1.4.3.4 India Market States and Outlook (2013-2023)
            1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2013-2023)
            1.4.4.2 Egypt Market States and Outlook (2013-2023)
            1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
            1.4.4.4 South Africa Market States and Outlook (2013-2023)
            1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 3M
        2.1.1 Business Overview
        2.1.2 Pulmonary Drug Delivery Systems Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 3M Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 GSK
        2.2.1 Business Overview
        2.2.2 Pulmonary Drug Delivery Systems Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 GSK Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 AstraZeneca
        2.3.1 Business Overview
        2.3.2 Pulmonary Drug Delivery Systems Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 Cipla
        2.4.1 Business Overview
        2.4.2 Pulmonary Drug Delivery Systems Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 Chiesi
        2.5.1 Business Overview
        2.5.2 Pulmonary Drug Delivery Systems Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 Boehringer Ingelheim
        2.6.1 Business Overview
        2.6.2 Pulmonary Drug Delivery Systems Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Aptar
        2.7.1 Business Overview
        2.7.2 Pulmonary Drug Delivery Systems Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8 Novartis
        2.8.1 Business Overview
        2.8.2 Pulmonary Drug Delivery Systems Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9 Philips Respironics
        2.9.1 Business Overview
        2.9.2 Pulmonary Drug Delivery Systems Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10 Omron Healthcare
        2.10.1 Business Overview
        2.10.2 Pulmonary Drug Delivery Systems Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.11 PARI
        2.11.1 Business Overview
        2.11.2 Pulmonary Drug Delivery Systems Type and Applications
            2.11.2.1 Product A
            2.11.2.2 Product B
        2.11.3 PARI Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.12 Skyepharma
        2.12.1 Business Overview
        2.12.2 Pulmonary Drug Delivery Systems Type and Applications
            2.12.2.1 Product A
            2.12.2.2 Product B
        2.12.3 Skyepharma Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.13 CareFusion
        2.13.1 Business Overview
        2.13.2 Pulmonary Drug Delivery Systems Type and Applications
            2.13.2.1 Product A
            2.13.2.2 Product B
        2.13.3 CareFusion Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.14 Shanghai Huarui
        2.14.1 Business Overview
        2.14.2 Pulmonary Drug Delivery Systems Type and Applications
            2.14.2.1 Product A
            2.14.2.2 Product B
        2.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.15 Taian Character
        2.15.1 Business Overview
        2.15.2 Pulmonary Drug Delivery Systems Type and Applications
            2.15.2.1 Product A
            2.15.2.2 Product B
        2.15.3 Taian Character Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.16 Chia Tai Tianqing
        2.16.1 Business Overview
        2.16.2 Pulmonary Drug Delivery Systems Type and Applications
            2.16.2.1 Product A
            2.16.2.2 Product B
        2.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pulmonary Drug Delivery Systems Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
    3.1 Global Pulmonary Drug Delivery Systems Sales and Market Share by Manufacturer (2016-2017)
    3.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Manufacturer (2016-2017)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Pulmonary Drug Delivery Systems Manufacturer Market Share in 2017
        3.3.2 Top 6 Pulmonary Drug Delivery Systems Manufacturer Market Share in 2017
    3.4 Market Competition Trend
4 Global Pulmonary Drug Delivery Systems Market Analysis by Regions
    4.1 Global Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Regions
        4.1.1 Global Pulmonary Drug Delivery Systems Sales and Market Share by Regions (2013-2018)
        4.1.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Regions (2013-2018)
    4.2 North America Pulmonary Drug Delivery Systems  Sales and Growth Rate (2013-2018)
    4.3 Europe Pulmonary Drug Delivery Systems  Sales and Growth Rate (2013-2018)
    4.4 Asia-Pacific Pulmonary Drug Delivery Systems  Sales and Growth Rate (2013-2018)
    4.5 South America Pulmonary Drug Delivery Systems  Sales and Growth Rate (2013-2018)
    4.6 Middle East and Africa Pulmonary Drug Delivery Systems  Sales and Growth Rate (2013-2018)
5 North America Pulmonary Drug Delivery Systems by Countries
    5.1 North America Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Countries
        5.1.1 North America Pulmonary Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
        5.1.2 North America Pulmonary Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
    5.2 United States Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    5.3 Canada Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    5.4 Mexico Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
6 Europe Pulmonary Drug Delivery Systems by Countries
    6.1 Europe Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Countries
        6.1.1 Europe Pulmonary Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
        6.1.2 Europe Pulmonary Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
    6.2 Germany Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    6.3 UK Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    6.4 France Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    6.5 Russia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    6.6 Italy Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
7 Asia-Pacific Pulmonary Drug Delivery Systems by Countries
    7.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Countries
        7.1.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
        7.1.2 Asia-Pacific Pulmonary Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
    7.2 China Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    7.3 Japan Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    7.4 Korea Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    7.5 India Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    7.6 Southeast Asia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
8 South America Pulmonary Drug Delivery Systems by Countries
    8.1 South America Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Countries
        8.1.1 South America Pulmonary Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
        8.1.2 South America Pulmonary Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
    8.2 Brazil Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    8.3 Argentina Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    8.4 Colombia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
9 Middle East and Africa Pulmonary Drug Delivery Systems by Countries
    9.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
        9.1.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
    9.2 Saudi Arabia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    9.3 UAE Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    9.4 Egypt Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    9.5 Nigeria Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
    9.6 South Africa Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
10 Global Pulmonary Drug Delivery Systems Market Segment by Type
    10.1 Global Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
        10.1.1 Global Pulmonary Drug Delivery Systems Sales and Market Share by Type (2013-2018)
        10.1.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Type (2013-2018)
    10.2 Nebulizers Sales Growth and Price
        10.2.1 Global Nebulizers Sales Growth (2013-2018)
        10.2.2 Global Nebulizers Price (2013-2018)
    10.3 Dry Powder Inhaler (DPI) Sales Growth and Price
        10.3.1 Global Dry Powder Inhaler (DPI) Sales Growth (2013-2018)
        10.3.2 Global Dry Powder Inhaler (DPI) Price (2013-2018)
    10.4 Metered Dose Inhaler (MDI) Sales Growth and Price
        10.4.1 Global Metered Dose Inhaler (MDI) Sales Growth (2013-2018)
        10.4.2 Global Metered Dose Inhaler (MDI) Price (2013-2018)
11 Global Pulmonary Drug Delivery Systems Market Segment by Application
    11.1 Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2013-2018)
    11.2 COPD Sales Growth (2013-2018)
    11.3 Asthma Sales Growth (2013-2018)
    11.4 Others Sales Growth (2013-2018)
12 Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
    12.1 Global Pulmonary Drug Delivery Systems Sales, Revenue and Growth Rate (2018-2023)
    12.2 Pulmonary Drug Delivery Systems Market Forecast by Regions (2018-2023)
        12.2.1 North America Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
        12.2.2 Europe Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
        12.2.3 Asia-Pacific Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
        12.2.4 South America Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
        12.2.5 Middle East and Africa Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
    12.3 Pulmonary Drug Delivery Systems Market Forecast by Type (2018-2023)
        12.3.1 Global Pulmonary Drug Delivery Systems Sales Forecast by Type (2018-2023)
        12.3.2 Global Pulmonary Drug Delivery Systems Market Share Forecast by Type (2018-2023)
    12.4 Pulmonary Drug Delivery Systems Market Forecast by Application (2018-2023)
        12.4.1 Global Pulmonary Drug Delivery Systems Sales Forecast by Application (2018-2023)
        12.4.2 Global Pulmonary Drug Delivery Systems Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

	List of Tables and Figures

Figure Pulmonary Drug Delivery Systems Picture
Table Product Specifications of Pulmonary Drug Delivery Systems
Figure Global Sales Market Share of Pulmonary Drug Delivery Systems by Types in 2017
Table Pulmonary Drug Delivery Systems Types for Major Manufacturers
Figure Nebulizers Picture
Figure Dry Powder Inhaler (DPI) Picture
Figure Metered Dose Inhaler (MDI) Picture
Figure Pulmonary Drug Delivery Systems Sales Market Share by Applications in 2017
Figure COPD Picture
Figure Asthma Picture
Figure Others Picture
Figure United States Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure France Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure UK Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure China Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure India Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Pulmonary Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Table 3M Basic Information, Manufacturing Base and Competitors
Table 3M Pulmonary Drug Delivery Systems Type and Applications
Table 3M Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Pulmonary Drug Delivery Systems Type and Applications
Table GSK Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Pulmonary Drug Delivery Systems Type and Applications
Table AstraZeneca Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Pulmonary Drug Delivery Systems Type and Applications
Table Cipla Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Chiesi Basic Information, Manufacturing Base and Competitors
Table Chiesi Pulmonary Drug Delivery Systems Type and Applications
Table Chiesi Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Pulmonary Drug Delivery Systems Type and Applications
Table Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aptar Basic Information, Manufacturing Base and Competitors
Table Aptar Pulmonary Drug Delivery Systems Type and Applications
Table Aptar Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Pulmonary Drug Delivery Systems Type and Applications
Table Novartis Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Philips Respironics Basic Information, Manufacturing Base and Competitors
Table Philips Respironics Pulmonary Drug Delivery Systems Type and Applications
Table Philips Respironics Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Omron Healthcare Basic Information, Manufacturing Base and Competitors
Table Omron Healthcare Pulmonary Drug Delivery Systems Type and Applications
Table Omron Healthcare Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table PARI Basic Information, Manufacturing Base and Competitors
Table PARI Pulmonary Drug Delivery Systems Type and Applications
Table PARI Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Skyepharma Basic Information, Manufacturing Base and Competitors
Table Skyepharma Pulmonary Drug Delivery Systems Type and Applications
Table Skyepharma Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CareFusion Basic Information, Manufacturing Base and Competitors
Table CareFusion Pulmonary Drug Delivery Systems Type and Applications
Table CareFusion Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shanghai Huarui Basic Information, Manufacturing Base and Competitors
Table Shanghai Huarui Pulmonary Drug Delivery Systems Type and Applications
Table Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taian Character Basic Information, Manufacturing Base and Competitors
Table Taian Character Pulmonary Drug Delivery Systems Type and Applications
Table Taian Character Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Chia Tai Tianqing Basic Information, Manufacturing Base and Competitors
Table Chia Tai Tianqing Pulmonary Drug Delivery Systems Type and Applications
Table Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Pulmonary Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure Global Pulmonary Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure Global Pulmonary Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table Global Pulmonary Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure Global Pulmonary Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure Global Pulmonary Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Figure Top 3 Pulmonary Drug Delivery Systems Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Pulmonary Drug Delivery Systems Manufacturer (Revenue) Market Share in 2017
Figure Global Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Global Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Global Pulmonary Drug Delivery Systems Sales by Regions (2013-2018)
Table Global Pulmonary Drug Delivery Systems Sales Market Share by Regions (2013-2018)
Table Global Pulmonary Drug Delivery Systems Revenue by Regions (2013-2018)
Figure Global Pulmonary Drug Delivery Systems Revenue Market Share by Regions in 2013
Figure Global Pulmonary Drug Delivery Systems Revenue Market Share by Regions in 2017
Figure North America Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Europe Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure South America Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure North America Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table North America Pulmonary Drug Delivery Systems Sales by Countries (2013-2018)
Table North America Pulmonary Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure North America Pulmonary Drug Delivery Systems Sales Market Share by Countries in 2013
Figure North America Pulmonary Drug Delivery Systems Sales Market Share by Countries in 2017
Table North America Pulmonary Drug Delivery Systems Revenue by Countries (2013-2018)
Table North America Pulmonary Drug Delivery Systems Revenue Market Share by Countries (2013-2018)
Figure North America Pulmonary Drug Delivery Systems Revenue Market Share by Countries in 2013
Figure North America Pulmonary Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure United States Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Canada Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Mexico Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Europe Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Europe Pulmonary Drug Delivery Systems Sales by Countries (2013-2018)
Table Europe Pulmonary Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Table Europe Pulmonary Drug Delivery Systems Revenue by Countries (2013-2018)
Figure Europe Pulmonary Drug Delivery Systems Revenue Market Share by Countries in 2016
Figure Europe Pulmonary Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure Germany Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure UK Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure France Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Russia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Italy Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Pulmonary Drug Delivery Systems Sales by Countries (2013-2018)
Table Asia-Pacific Pulmonary Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Pulmonary Drug Delivery Systems Sales Market Share by Countries 2017
Table Asia-Pacific Pulmonary Drug Delivery Systems Revenue by Countries (2013-2018)
Figure Asia-Pacific Pulmonary Drug Delivery Systems Revenue Market Share by Countries 2017
Figure China Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Japan Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Korea Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure India Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Southeast Asia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure South America Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table South America Pulmonary Drug Delivery Systems Sales by Countries (2013-2018)
Table South America Pulmonary Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure South America Pulmonary Drug Delivery Systems Sales Market Share by Countries in 2017
Table South America Pulmonary Drug Delivery Systems Revenue by Countries (2013-2018)
Table South America Pulmonary Drug Delivery Systems Revenue Market Share by Countries (2013-2018)
Figure South America Pulmonary Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure Brazil Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Argentina Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Colombia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pulmonary Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Pulmonary Drug Delivery Systems Sales by Countries (2013-2018)
Table Middle East and Africa Pulmonary Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Pulmonary Drug Delivery Systems Sales Market Share by Countries in 2017
Table Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Countries (2013-2018)
Table Middle East and Africa Pulmonary Drug Delivery Systems Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Pulmonary Drug Delivery Systems Revenue Market Share by Countries in 2013
Figure Middle East and Africa Pulmonary Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure Saudi Arabia Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure UAE Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Egypt Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Nigeria Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure South Africa Pulmonary Drug Delivery Systems Sales and Growth Rate (2013-2018)
Table Global Pulmonary Drug Delivery Systems Sales by Type (2013-2018)
Table Global Pulmonary Drug Delivery Systems Sales Share by Type (2013-2018)
Table Global Pulmonary Drug Delivery Systems Revenue by Type (2013-2018)
Table Global Pulmonary Drug Delivery Systems Revenue Share by Type (2013-2018)
Figure Global Nebulizers Sales Growth (2013-2018)
Figure Global Nebulizers Price (2013-2018)
Figure Global Dry Powder Inhaler (DPI) Sales Growth (2013-2018)
Figure Global Dry Powder Inhaler (DPI) Price (2013-2018)
Figure Global Metered Dose Inhaler (MDI) Sales Growth (2013-2018)
Figure Global Metered Dose Inhaler (MDI) Price (2013-2018)
Table Global Pulmonary Drug Delivery Systems Sales by Application (2013-2018)
Table Global Pulmonary Drug Delivery Systems Sales Share by Application (2013-2018)
Figure Global Asthma Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Pulmonary Drug Delivery Systems Sales, Revenue and Growth Rate (2018-2023)
Table Global Pulmonary Drug Delivery Systems Sales Forecast by Regions (2018-2023)
Table Global Pulmonary Drug Delivery Systems Market Share Forecast by Regions (2018-2023)
Figure North America Sales Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
Figure Europe Sales Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
Figure Asia-Pacific Sales Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
Figure South America Sales Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
Figure Middle East and Africa Sales Pulmonary Drug Delivery Systems Market Forecast (2018-2023)
Table Global Pulmonary Drug Delivery Systems Sales Forecast by Type (2018-2023)
Table Global Pulmonary Drug Delivery Systems Market Share Forecast by Type (2018-2023)
Table Global Pulmonary Drug Delivery Systems Sales Forecast by Application (2018-2023)
Table Global Pulmonary Drug Delivery Systems Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List

Related Reports

Global Electrocardiograph (ECG) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

An electrocardiograph is a machine that is used to perform electrocardiography, and produces the electrocardiogram. Scope of the Report: This report focuses on the Electrocardiograph (ECG) in global ...read more

Global Digital X-ray Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Digital radiography is a form of X-ray imaging, where digital X-ray sensors are used instead of traditional photographic film. Scope of the Report: This report focuses on the Digital X-ray Devices in ...read more

Global Pipettes and Pipettors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Scope of the Report: This report focuses on the Pipettes and Pipettors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report catego ...read more

Global Veterinary Point of Care Blood Gas Analyzers Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Veterinary blood gas analyzers are used to measure pH, blood gases, electrolytes, and metabolites parameters in blood specimen. They offer test convenience, and facilitate rapid diagnosis. Scope of t ...read more

Global Vertebral Compression Fracture Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Vertebral compression fracture (VCF) generally occurs when the block-like part of a single bone of the spine (vertebra) is compressed due to trauma. The surgical approach for VCF treatment involves in ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.